These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36056446)

  • 1. Researcher perspectives on ethics considerations in epigenetics: an international survey.
    Dupras C; Knoppers T; Palmour N; Beauchamp E; Liosi S; Siebert R; Berner AM; Beck S; Charest I; Joly Y
    Clin Epigenetics; 2022 Sep; 14(1):110. PubMed ID: 36056446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and opportunities for ELSI early career researchers.
    Bell J; Ancillotti M; Coathup V; Coy S; Rigter T; Tatum T; Grewal J; Akcesme FB; Brkić J; Causevic-Ramosevac A; Milovanovic G; Nobile M; Pavlidis C; Finlay T; Kaye J;
    BMC Med Ethics; 2016 Jul; 17(1):37. PubMed ID: 27390930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics, ethics, law and society: A multidisciplinary review of descriptive, instrumental, dialectical and reflexive analyses.
    Dupras C; Saulnier KM; Joly Y
    Soc Stud Sci; 2019 Oct; 49(5):785-810. PubMed ID: 31366289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics ELSI: Darker Than You Think?
    Joly Y; So D; Saulnier K; Dyke SOM
    Trends Genet; 2016 Oct; 32(10):591-592. PubMed ID: 27460649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical implications of epigenetics in the era of personalized medicine.
    Santaló J; Berdasco M
    Clin Epigenetics; 2022 Mar; 14(1):44. PubMed ID: 35337378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Points-to-consider on the return of results in epigenetic research.
    Dyke SOM; Saulnier KM; Dupras C; Webster AP; Maschke K; Rothstein M; Siebert R; Walter J; Beck S; Pastinen T; Joly Y
    Genome Med; 2019 May; 11(1):31. PubMed ID: 31122281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic/genomic testing: defining the parameters for ethical, legal and social implications (ELSI).
    Ascencio-Carbajal T; Saruwatari-Zavala G; Navarro-Garcia F; Frixione E
    BMC Med Ethics; 2021 Nov; 22(1):156. PubMed ID: 34814901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of epigenetics in dermatological research and skin management.
    He J; He H; Qi Y; Yang J; Zhi L; Jia Y
    J Cosmet Dermatol; 2022 May; 21(5):1920-1930. PubMed ID: 34357681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ambiguous nature of epigenetic responsibility.
    Dupras C; Ravitsky V
    J Med Ethics; 2016 Aug; 42(8):534-41. PubMed ID: 27015741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation technologies and data analytical approaches for epigenomics.
    Mensaert K; Denil S; Trooskens G; Van Criekinge W; Thas O; De Meyer T
    Environ Mol Mutagen; 2014 Apr; 55(3):155-70. PubMed ID: 24327356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics in the Neoliberal "Regime of Truth": A Biopolitical Perspective on Knowledge Translation.
    Dupras C; Ravitsky V
    Hastings Cent Rep; 2016; 46(1):26-35. PubMed ID: 26659400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Society of Psychiatric Genetics Ethics Committee: Issues facing us.
    Lázaro-Muñoz G; Sabatello M; Huckins L; Peay H; Degenhardt F; Meiser B; Lencz T; Soda T; Docherty A; Crepaz-Keay D; Austin J; Peterson RE; Davis LK;
    Am J Med Genet B Neuropsychiatr Genet; 2019 Dec; 180(8):543-554. PubMed ID: 31124312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and Opportunities in Social Epigenomics and Cancer.
    Banaudha K; Kumar V; Verma M
    Methods Mol Biol; 2018; 1856():233-243. PubMed ID: 30178255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical, legal, and social issues (ELSI) in rare diseases: a landscape analysis from funders.
    Hartman AL; Hechtelt Jonker A; Parisi MA; Julkowska D; Lockhart N; Isasi R
    Eur J Hum Genet; 2020 Feb; 28(2):174-181. PubMed ID: 31537898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of epigenetics in kidney cell biology.
    Li LX; Agborbesong E; Zhang L; Li X
    Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaco-epigenomics: On the Road of Translation Medicine.
    López-Camarillo C; Gallardo-Rincón D; Álvarez-Sánchez ME; Marchat LA
    Adv Exp Med Biol; 2019; 1168():31-42. PubMed ID: 31713163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The social construction of the social epigenome and the larger biological context.
    Deichmann U
    Epigenetics Chromatin; 2020 Sep; 13(1):37. PubMed ID: 32967714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the epigenetics of fibroblast biology and fibrotic diseases.
    Ulukan B; Sila Ozkaya Y; Zeybel M
    Curr Opin Pharmacol; 2019 Dec; 49():102-109. PubMed ID: 31731224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy.
    Hussain S; Tulsyan S; Dar SA; Sisodiya S; Abiha U; Kumar R; Mishra BN; Haque S
    Semin Cancer Biol; 2022 Aug; 83():441-451. PubMed ID: 34182144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenomics, Pharmacoepigenomics, and Personalized Medicine in Cervical Cancer.
    Kabekkodu SP; Chakrabarty S; Ghosh S; Brand A; Satyamoorthy K
    Public Health Genomics; 2017; 20(2):100-115. PubMed ID: 28521327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.